Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Andre Uddin
RESE
Andre Uddin
Research Capital
Wall Street Analyst
★★★★☆
#542
on 13Foresight · ranked by our own returns
60%
Success Rate
+45.5%
Average Return
3 of 5 calls profitable · +33.0% vs benchmark
📈 Across the calls we could measure, roughly 60% of Andre Uddin's ratings turned a profit when each position was held for 1 year — averaging +45.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

12 Buy 0 Hold 0 Sell
Andre's Stock Coverage 21 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
TSE:EDT
Spectral Medical
 May 31, 2026 BUY Strong Buy
+79.6% avg upside
3 analysts
$3.50
157.35% Upside
 ·
TSE:TLT
Theralase Technologies
 May 25, 2026 BUY Strong Buy
+204.4% avg upside
1 analyst
$0.70
204.38% Upside
 ·
TSE:COV
Covalon Technologies
 May 22, 2026 BUY Strong Buy
+27.2% avg upside
1 analyst
$2.90
27.18% Upside
 ·
NGEN
NervGen Pharma
 Apr 10, 2026 BUY Strong Buy
+358.7% avg upside
8 analysts
$5.50
149.96% Upside
 -48.6%
TSE:SVA
Sernova
 Jun 19, 2025 BUY Strong Buy
+2384.8% avg upside
3 analysts
$0.60
274.94% Upside
 ·
TSE:MDNA
Medicenna Therapeutics Corp
 Apr 28, 2025 BUY Strong Buy
+1091.5% avg upside
9 analysts
$3.75
772.12% Upside
 ·
TSE:GUD
Knight Therapeutics
 Mar 11, 2025 BUY Strong Buy
-10.8% avg upside
7 analysts
$7.50
19.63% Downside
 ·
TSE:MDP
Medexus Pharmaceuticals Inc
 Mar 26, 2024 BUY Strong Buy
+31.8% avg upside
5 analysts
$5.90
43.59% Upside
 ·
ABILF
Ability
 Aug 31, 2023 BUY Strong Buy
+21899900.0% avg upside
2 analysts
$0.80
799899.98% Upside
 ·
VPHIF
Valeo Pharma
 Jun 14, 2023 BUY Strong Buy
+116771165.0% avg upside
2 analysts
$0.71
70934499.91% Upside
 ·
TSE:GREY
Grey Matters Health
 May 10, 2021 BUY Strong Buy
+5002.0% avg upside
1 analyst
$25.00
5002.03% Upside
 ·
SLHGF
Skylight Health Group
 Dec 11, 2020 BUY Strong Buy
+799999900.1% avg upside
1 analyst
$8.00
799999900.08% Upside
 ·
TSE:APLI
Appili Therapeutics Inc Class A
 Oct 30, 2020 BUY Buy
+8252.0% avg upside
3 analysts
$2.26
14937.27% Upside
 ·
TSE:CPH
Cipher Pharmaceuticals
 May 08, 2020 BUY Strong Buy
-45.9% avg upside
4 analysts
$1.50
90.65% Downside
 ·
TSE:MPH
Medicure
 Apr 16, 2020 HOLD Hold
+180.0% avg upside
1 analyst
$2.80
180.03% Upside
 ·
TSE:PRN
Profound Medical
 Apr 07, 2020 HOLD Strong Buy
+96.1% avg upside
11 analysts
$16.20
68.08% Upside
 ·
IMVIF
IMV
 Feb 26, 2020 BUY Buy
+2444773950.1% avg upside
7 analysts
$6.03
602944000.09% Upside
 ·
GRCE
Grace Therapeutics
 Jan 13, 2020 BUY Strong Buy
+153.0% avg upside
9 analysts
 — -15.8%
AUPH
Aurinia Pharmaceuticals
 Oct 31, 2019 BUY Strong Buy
-7.2% avg upside
12 analysts
$10.00
39.18% Downside
 +222.6%
PMN
ProMIS Neurosciences
 Nov 13, 2017 BUY Strong Buy
+583.1% avg upside
6 analysts
 — +11.1%
HSDT
Solana Company
 May 17, 2017 BUY Strong Buy
+1277.5% avg upside
8 analysts
$15.00
825.84% Upside
 +58.3%
🔒 16 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Andre Uddin — Frequently Asked Questions
How accurate are Andre Uddin's stock ratings?
Based on the calls 13Foresight could measure, about 60% of Andre's ratings were profitable over a one-year hold, with an average return of +45.5% per rating, or +33.0% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Andre ranked on 13Foresight?
Andre Uddin is currently ranked #542 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Andre cover?
Andre most recently has ratings on TSE:EDT, TSE:TLT, TSE:COV, NGEN, TSE:SVA, TSE:MDNA, TSE:GUD, TSE:MDP, ABILF, VPHIF, TSE:GREY, SLHGF and 9 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.